Zhejiang Asia-Pacific Pharmaceutical

Zhejiang Asia-Pacific Pharmaceutical is a China-based pharmaceutical company that specializes in the research, development, and large-scale production of chemical drug preparations and active pharmaceutical ingredients (APIs). The company's extensive product portfolio is primarily centered on anti-infective medications, including a wide range of cephalosporin and macrolide antibiotics. Additionally, it produces treatments for digestive system disorders, cardiovascular diseases, and viral infections. Headquartered in Shaoxing, the firm operates multiple GMP-certified facilities and maintains a strong distribution network within the Chinese domestic market. While the company has navigated financial restructuring and regulatory challenges in recent years, it remains a significant manufacturer of essential generic medicines.